secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001683168-25-008618
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics lists official disclosure channels including social media
------------------------------------------------------------------------------

- Company announced it will use website, press releases, SEC filings, and social media for material information.
- Social media channels include X (@ActuateThera), LinkedIn, and Facebook.
- Investors can subscribe to press releases and SEC filings on the company's investor relations page.
- List may be updated from time to time; no other material news disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/0001683168-25-008618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000168316825008618/actuate_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-008618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer